PYXIS ONCOLOGY, INC.
PYXIS ONCOLOGY, INC. logo
PYXS

PYXIS ONCOLOGY, INC. (PYXS)

$1.454.61%

Live
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$1.42
Day's Range
$1.55
$1.34
52-Week Range
$13.29
1 month return19.15%
3 month return43.28%
1 year return87.97%
5 year return88.48%

Company Information

Pyxis Oncology, Inc. is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. Pyxis develops its product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion. Since its launch in 2019, Pyxis has developed a broad portfolio of novel antibody drug conjugate, or ADC, product candidates, and monoclonal antibody, or mAb, preclinical discovery programs that it is developing as monotherapies and in combination with other therapies.
OrganizationPYXIS ONCOLOGY, INC.
Employees73
CEOMr. John L. Flavin M.B.A., MBA, Ph.D.

Analyst Recommendation

based on 11 analysts ratings

Buy
81%
Buy
18%
Hold
0%
Sell

Based on 11 Wall street analysts offering stock ratings for PYXIS ONCOLOGY, INC.(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 658.62%

Current

$1.45

Target

$11.0

Recommendation Trend

Based on 11 analyst

Current1M Ago3M Ago
Buy
9
9
9
Hold
2
2
2
Sell
0
0
0
Consensus
BUY
BUY
BUY

Highlights

Market Capitalization
49.8M
Book Value
$6.45
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-4.34
Wall Street Target Price
11.0

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
0.26
Enterprise Value
-132997870
Enterprise Value/Revenue
0.0
Enterprise Value/Ebitda
1.31

Technicals

50 Day MA
1.73
200 Day MA
2.98

Institutional Holdings

LAURION CAPITAL MANAGEMENT LP

9.03%

Bvf Inc

8.37%

Perceptive Advisors LLC

4.36%

Citadel Advisors Llc

4.33%

TANG CAPITAL MANAGEMENT LLC

3.93%

Credit Suisse First Boston (CSFB)

2.75%

Discover more

Frequently Asked Questions

What is PYXIS ONCOLOGY, INC. share price today?

Can Indians buy PYXIS ONCOLOGY, INC. shares?

How can I buy PYXIS ONCOLOGY, INC. shares from India?

Can Fractional shares of PYXIS ONCOLOGY, INC. be purchased?

What are the documents required to start investing in PYXIS ONCOLOGY, INC. stocks?

What are today’s High and Low prices of PYXIS ONCOLOGY, INC.?

What are today’s traded volumes of PYXIS ONCOLOGY, INC.?

What is today’s market capitalisation of PYXIS ONCOLOGY, INC.?

What is the 52 Week High and Low Range of PYXIS ONCOLOGY, INC.?

How much percentage PYXIS ONCOLOGY, INC. is down from its 52 Week High?

How much percentage PYXIS ONCOLOGY, INC. is up from its 52 Week low?

What are the historical returns of PYXIS ONCOLOGY, INC.?

Who is the Chief Executive Officer (CEO) of PYXIS ONCOLOGY, INC.?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*